west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "面部" 63 results
  • 原发性颈面部恶性淋巴瘤化学治疗的临床分析

    【摘要】目的 观察原发性颈面部恶性淋巴瘤手术前后化学治疗(化疗)的治疗效果。方法 回顾性分析18例颈面部恶性淋巴瘤患者的发病年龄和临床表现。结果 18例患者中,2例1.5、2.0年死亡,随访失访1例。存活的15例患者中,2、3年的4例,3、4年的4例,4年以上的7例。结论 恶性淋巴瘤的治疗主要以化疗为主,且以联合化疗效果最佳;手术前后化疗对恶性淋巴瘤的近期临床疗效满意。

    Release date:2016-09-08 09:45 Export PDF Favorites Scan
  • Effect of urokinase thrombolytic therapy for optic artery and retinal artery occlusion caused by facial microinjection with hyaluronic acid and spontaneous retinal artery occlusion

    ObjectiveTo compare the clinical effects of urokinase thrombolytic therapy for optic artery occlusion (OAO) and retinal artery occlusion (RAO) caused by facial microinjection with hyaluronic acid and spontaneous RAO.MethodsFrom January 2014 to February 2018, 22 eyes of 22 patients with OAO and RAO caused by facial microinjection of hyaluronic acid who received treatment in Xi'an Fourth Hospital were enrolled in this retrospective study (hyaluronic acid group). Twenty-two eyes of 22 patients with spontaneous RAO were selected as the control group. The BCVA examination was performed using the international standard visual acuity chart, which was converted into logMAR visual acuity. FFA was used to measure arm-retinal circulation time (A-Rct) and filling time of retinal artery and its branches (FT). Meanwhile, MRI examination was performed. There were significant differences in age and FT between the two groups (t=14.840, 3.263; P=0.000, 0.003). The differecens of logMAR visual acuity, onset time and A-Rct were not statistically significant between the two groups (t=0.461, 0.107, 1.101; P=0.647, 0.915, 0.277). All patients underwent urokinase thrombolysis after exclusion of thrombolytic therapy. Among the patients in the hyaluronic acid group and control group, there were 6 patients of retrograde ophthalmic thrombolysis via the superior pulchlear artery, 6 patients of retrograde ophthalmic thrombolysis via the internal carotid artery, and 10 patients of intravenous thrombolysis. FFA was reviewed 24 h after treatment, and A-Rct and FT were recorded. Visual acuity was reviewed 30 days after treatment. The occurrence of adverse reactions during and after treatment were observed. The changes of logMAR visual acuity, A-Rct and FT before and after treatment were compared between the two groups using t-test.ResultsAt 24 h after treatment, the A-Rct and FT of the hyaluronic acid group were 21.05±3.42 s and 5.05±2.52 s, which were significantly shorter than before treatment (t=4.569, 2.730; P=0.000, 0.000); the A-Rct and FT in the control group were 19.55±4.14 s and 2.55±0.91 s, which were significantly shorter than before treatment (t=4.114, 7.601; P=0.000, 0.000). There was no significant difference in A-Rct between the two groups at 24 h after treatment (t=1.311, P=0.197). The FT difference was statistically significant between the two groups at 24 h after treatment (t=4.382, P=0.000). There was no significant difference in the shortening time of A-Rct and FT between the two groups (t=0.330, 0.510; P=0.743, 0.613). At 30 days after treatment, the logMAR visual acuity in the hyaluronic acid group and the control group were 0.62±0.32 and 0.43±0.17, which were significantly higher than those before treatment (t=2.289, 5.169; P=0.029, 0.000). The difference of logMAR visual acuity between the two groups after treatment was statistically significant (t=2.872, P=0.008). The difference in logMAR visual acuity before and after treatment between the two groups was statistically significant (t=2.239, P=0.025). No ocular or systemic adverse reactions occurred during or after treatment in all patients. ConclusionsUrokinase thrombolytic therapy for OAO and RAO caused by facial microinjection with hyaluronic acid and spontaneous RAO is safe and effective, with shortening A-Rct, FT and improving visual acuity. However, the improvement of visual acuity after treatment of OAO and RAO caused by facial microinjection with hyaluronic acid is worse than that of spontaneous RAO.

    Release date:2020-01-11 10:26 Export PDF Favorites Scan
  • Study of the Relationship between Operating Room Working Environment and Facial Skin Damage in Nurses

    ObjectiveTo understand the status of the nurse facial skin damage because of regular exposure to a variety of environmental damage factors, in order to cause enough attention and find the solution. MethodsBetween January 2013 and June 2014, we used a self-made questionnaire to survey 122 operating room nurses from grade three first-rate hospitals by random sampling on the facial skin damage status. Then, we analyzed the risk factors of operating room nurses facial skin damage and put forward such countermeasures as improving working environment, increasing service facilities, reducing pollution and biological, chemical, psychological factors, and selecting and using surgical masks properly and promoting facial skin protective measures. ResultsThe survey showed that 93.3% of all the investigated operating room nurses had facial skin problems which mainly was rough dry skin (99.2%); 76.7% of the nurses thought that it was related to the nature of work, and 72.5% of them considered that metal fatigue was the main influence factor. ConclusionWe should strengthen the nurses’ own protection consciousness, enact all kinds of protective measures, strictly implement the system of protection and take effective protective measures as to reduce the operating room nurses facial skin damage.

    Release date: Export PDF Favorites Scan
  • 透明质酸钠类面部注射产品临床试验设计思路

    近年来,企业研发用于除皱的透明质酸钠类面部注射产品日益增多。此类产品在国内按照第三类医疗器械进行管理,即属于管理类别最高的医疗器械,注册申报时需提交规范的临床试验资料以支持其安全性和有效性。因此,对于此类产品如何进行科学的临床试验设计,如何选择合理的临床评价标准,如何按照不同的产品适应证界定临床试验单元,如何对临床数据进行充分的分析,以及对于已上市的产品如何进行临床随访数据的收集,则是企业和临床试验机构共同关注的问题。

    Release date:2016-09-08 09:18 Export PDF Favorites Scan
  • REPAIR OF FACE SOFT TISSUE DEFECT WITH PREFABRICATED THE NECK EXPANDER FLAP WITH THE VESSLES OF TEMPORALIS SUPERFICIALIS

    Objective To probe the principle and the method to repair facial soft tissue defect with the prefabricated expander flap the neck with the vessles of temporalis superficialis. Methods The expandor was implanted into the surface layer of the platysma in neck. The pedicle of the expander flap contained the arteria temporalis superficialis and its ramux parietalis. After 3 months, the prefabricated island expander flaps pedicled with the arteria temporalis superficialis and its ramux parietalis could be transferred to the face. From 1998 to 2003, 6 cases of facial soft tissue defects were repaired. The maximal flap size was 12 cm×8 cm.Thepedicel length was 7.8 cm.Results After a follow-up of 3-6 months, all expander flaps survived. The excellent function and cosmetic result were achieved. Conclusion The prefabricated expander flaps of the neck pedicled with the arteria temporalis superficialis and its ramux parietalis can be transferred to the upperface to repair tissues defect. The supply of blood of the prefabricated expander flaps were safe and reliable. The survived areas of the flaps are directly proportional to the areas of temporalis superficialis fascia combining the expander flaps. 

    Release date:2016-09-01 09:29 Export PDF Favorites Scan
  • 颜面部神经纤维瘤病连续整形修复术一例

    【摘 要】 目的 报道1 例连续手术整形修复面部巨大神经纤维瘤病,探讨其面部严重畸形的修复整形方法。 方法 患者,男,22 岁。神经纤维瘤病呈“象面”严重畸形。患者右颜面巨大囊袋样包块29 cm × 17 cm,侵及额顶、颞部及鼻口部,右眼球脱出,右睑裂8 cm,右鼻孔8.5 cm,大口畸形。CT 及MRI 检查:右枕骨缺损,右侧眼眶内下壁骨质变形缺损下移,额颞脑组织通过缺损疝出,右上、下颌骨变薄变形。一期手术面部肿瘤主体切除,将脱出变性眼球及变性腮腺摘除,行眼眶底钛网重建,组合皮瓣成型术,切除摘出物重4 kg。二期手术时于4 个月后行残余肿瘤继续切除,阔筋膜悬吊,组合瓣鼻唇整形术。三期手术于二期术后4 个月进行,再次切取阔筋膜悬吊,面部精细整形术。 结果 8 个月后手术完成,术后随访4 个月,面部整形效果满意。患者生活自如,步态平稳,能平卧。 结论 对于面部巨大神经纤维瘤,手术治疗是目前唯一可行的方法。连续分期整形术,可根据分期手术结果充分调整皮瓣设计及成型方法,同时多次修复悬吊可最大程度减少组织下垂,是一种较为实用安全的方法。

    Release date:2016-09-01 09:09 Export PDF Favorites Scan
  • 胸大肌肌皮瓣修复口腔颌面部肿瘤切除后的缺损

    Release date:2016-09-01 09:26 Export PDF Favorites Scan
  • APPLICATION OF FACIAL TISSUE EXPANDER FIBROUS ENVELOPE FOR TENSION REDUCTION

    Objective To investigate the application of the fibrous envelope of tissue expanders for the tension reduction. Methods Between June 2005 and May 2011, 21 patients with facial scar were treated with skin soft tissue expansion. There were 6 males and 15 females, aged 19-33 years (mean, 24.5 years), including 19 cases of hypertrophic scar and 2 cases of atrophic scar with disease duration of 1-31 years. The scars ranged from 4 cm × 2 cm to 25 cm × 10 cm. The tissue expander was implanted under normal skin adjacent to lesions in the first stage. And the post-expanded skin flap was designed as advance flap or transpositional flap as supplement in the second stage. Fibrous envelope at the base was fixed to the periosteum or fascia nearby first, and then sutures were used between envelopes at the base and on the skin flap or to the dermis of the skin flap to keep the mouth and lower eyelid in proper position. It reduced the tension of incision and maintained the contour of the face and neck. Results After the first stage operation, 2 cases had replaced expanders because of infection and leakage. No complication of infection or hematoma occurred after the second stage operation. The patients were followed up 1-18 months (mean, 10.2 months); of them,12 were followed up more than 1 year. No secondary deformity (deviation of mouth angle, eyebrows pulling, or eyelid ectropion) occurred. The flaps had good appearance and color. The satisfactory results were achieved. Conclusion In skin soft tissue expansion of the face, the fibrous envelopes at the base could reduce the tension of the incision and prevent the deformity of the mouth and lower eyelids.

    Release date:2016-08-31 04:24 Export PDF Favorites Scan
  • PROGRESS OF AUTOLOGOUS FAT GRAFTING IN CLINICAL APPLICATIONS OF THE FACE

    【Abstract】 Objective To review the progress of autologous fat grafting of the face and outline different arguments in this field. Methods Recent literature concerning autologous fat grafting of the face was reviewed and analyzed. Results The applications and techniques for autologous fat grafting have been matured increasingly. It not only can adjust the proportion of facial contours, restore tissue volume, but also can improve the local skin texture. Reliable clinical results have achieved in facial augmentation and rejuvenation. Although there are arguments about donor site, harvesting technique, processing technique, and grafting technique, the basic principle is the same. Conclusion From the perspective of evidence-based medicine, clinicians are rich in clinical experience, but objective evidence is insufficient. So further researches should be carried to look for scientific evidences.

    Release date:2016-08-31 04:21 Export PDF Favorites Scan
  • 耳后瓣联合多瓣修复颞部恶性肿瘤大缺损一例

    目的总结1例应用耳后瓣联合多瓣修复右颞部恶性肿瘤组织大缺损的效果。 方法2016年1月收治1例右颞部肿物男性患者,75岁;肿物大小约为4 cm×4 cm。术中病理示鳞状细胞癌。术中行扩大切除术、面神经解剖术,肿物切除后组织缺损范围为8 cm×8 cm。于缺损部邻近组织设计制备耳后瓣、鼻唇沟瓣、颊瓣、颈胸皮瓣,大小分别约为4 cm×3 cm、4 cm×2 cm、4 cm×3 cm、8 cm×4 cm,联合修复创面。 结果术后皮瓣血运良好,均成活,供受区创面均Ⅰ期愈合。术后1个月内因皮瓣张力过大,右口角向上偏移;外眦受牵拉外移,致右眼裂变小。术后3个月随访,右侧口角位置基本恢复正常,眼周稍肿胀,眼裂稍小,皮瓣色泽、质地均良好。术后4个月面部外形对称,表情自然协调正常,患者满意。 结论耳后瓣联合多瓣修复颞部组织大缺损效果良好,手术方法较简便,尤其适合老年患者。

    Release date:2016-10-21 06:36 Export PDF Favorites Scan
7 pages Previous 1 2 3 ... 7 Next

Format

Content